Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism is common body hair growth due to genetics and hormones, and while not a disease, it can be distressing; virilisation includes hirsutism with other male traits and needs medical attention.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

GnRH-a or orchiectomy is more effective than anti-androgens for managing hormone levels in transgender women.

Early diagnosis and treatment of PCOS in young people is important to prevent long-term health problems.

Early detection and comprehensive care improve long-term health in PCOS.

Genetic testing for cancer risk can lead to early and life-saving treatments in people without symptoms.

Men with high genetic risk for Polycystic Ovary Syndrome (PCOS) have increased chances of obesity, type 2 diabetes, heart disease, and hair loss, showing PCOS risk factors can affect both genders.

Machine learning identified three unique subtypes of androgen excess in women with PCOS, each with different metabolic risks.

PCOS is a common hormonal disorder with symptoms like irregular periods and excess hair growth, managed with lifestyle changes and medications.

Underweight women with PCOS can have insulin resistance, and treatment with metformin and dexamethasone can improve symptoms.

Women with PCOS often face menstrual issues, weight gain, and stress, affecting their quality of life.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

PCOS requires personalized treatment to manage symptoms and improve fertility and quality of life.

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

Antiandrogens are used to manage polycystic ovary syndrome by reducing androgen levels or controlling their effects, often combined with lifestyle changes and other treatments.

Insulin changes sex hormone levels in women with polycystic ovary syndrome without affecting other hormone releases.

Women of reproductive age with polycystic ovary syndrome often experience hair loss.

Vorasidenib can cause unusual hair growth.

A new gene mutation linked to Olmsted syndrome may increase cancer risk, suggesting the need for ongoing patient monitoring.

Myo-inositol-based treatments greatly improve pregnancy chances for women with PCOS.

Women with PCOS have higher PSA levels, which are linked to increased male hormone levels and hirsutism.

Androgen measurement helps diagnose PCOS, but accuracy varies, needing standard methods.

New treatments for PCOS show promise, including both medication and non-medication options.

High AMH levels are linked to PCOS in women and may have a male equivalent with similar traits.

PCOS is a complex hormonal disorder with no clear cause or single diagnostic test, and current treatments focus on symptoms.

The treatment temporarily improved symptoms of hyperandrogenism in adolescents.

A woman developed male traits from accidental contact with her husband's testosterone gel.

Creating specific biological indicators is important for early detection and treatment of PCOS.

Women with PCOS-related infertility can often conceive with treatments like clomiphene and metformin, but managing pregnancy complications is important.

The conclusion is that hirsutism is strongly linked to PCOS and higher levels of certain hormones, but not to DHEAS, prolactin, cortisol, or TSH.